Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Immunosuppressed Adult Zebrafish Model of Mucormycosis.

Tatara AM, Wurster S, Lockworth CR, Albert ND, Walsh TJ, Mikos AG, Eisenhoffer GT, Kontoyiannis DP.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00698-18. doi: 10.1128/AAC.00698-18. Print 2018 Nov. No abstract available.


Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Tatara AM, Rozich AJ, Kontoyiannis PD, Watson E, Albert ND, Bennett GN, Mikos AG.

J Mater Sci Mater Med. 2018 May 11;29(5):70. doi: 10.1007/s10856-018-6073-1.


Large Animal Models of an In Vivo Bioreactor for Engineering Vascularized Bone.

Akar B, Tatara AM, Sutradhar A, Hsiao HY, Miller M, Cheng MH, Mikos AG, Brey EM.

Tissue Eng Part B Rev. 2018 Aug;24(4):317-325. doi: 10.1089/ten.TEB.2018.0005. Epub 2018 Apr 12.


Invasive Cutaneous Facial Mucormycosis in a Trauma Patient.

Jundt JS, Wong MEK, Tatara AM, Demian NM.

J Oral Maxillofac Surg. 2018 Sep;76(9):1930.e1-1930.e5. doi: 10.1016/j.joms.2018.01.022. Epub 2018 Feb 16.


Drug delivery and tissue engineering to promote wound healing in the immunocompromised host: Current challenges and future directions.

Tatara AM, Kontoyiannis DP, Mikos AG.

Adv Drug Deliv Rev. 2018 Apr;129:319-329. doi: 10.1016/j.addr.2017.12.001. Epub 2017 Dec 6. Review.


Synthesis and Characterization of Diol-Based Unsaturated Polyesters: Poly(diol fumarate) and Poly(diol fumarate-co-succinate).

Tatara AM, Watson E, Satish T, Scott DW, Kontoyiannis DP, Engel PS, Mikos AG.

Biomacromolecules. 2017 Jun 12;18(6):1724-1735. doi: 10.1021/acs.biomac.7b00044. Epub 2017 May 17.


Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.

Heo ST, Tatara AM, Jiménez-Ortigosa C, Jiang Y, Lewis RE, Tarrand J, Tverdek F, Albert ND, Verweij PE, Meis JF, Mikos AG, Perlin DS, Kontoyiannis DP.

Clin Infect Dis. 2017 Jul 15;65(2):216-225. doi: 10.1093/cid/cix297.


Effects of Local Antibiotic Delivery from Porous Space Maintainers on Infection Clearance and Induction of an Osteogenic Membrane in an Infected Bone Defect.

Shah SR, Smith BT, Tatara AM, Molina ER, Lee EJ, Piepergerdes TC, Uhrig BA, Guldberg RE, Bennett GN, Wenke JC, Mikos AG.

Tissue Eng Part A. 2017 Feb;23(3-4):91-100. doi: 10.1089/ten.TEA.2016.0389. Epub 2017 Jan 11.


Reconstruction of large mandibular defects using autologous tissues generated from in vivo bioreactors.

Tatara AM, Shah SR, Demian N, Ho T, Shum J, van den Beucken JJJP, Jansen JA, Wong ME, Mikos AG.

Acta Biomater. 2016 Nov;45:72-84. doi: 10.1016/j.actbio.2016.09.013. Epub 2016 Sep 12.


Acellular mineral deposition within injectable, dual-gelling hydrogels for bone tissue engineering.

Vo TN, Tatara AM, Santoro M, van den Beucken JJ, Leeuwenburgh SC, Jansen JA, Mikos AG.

J Biomed Mater Res A. 2017 Jan;105(1):110-117. doi: 10.1002/jbm.a.35875. Epub 2016 Sep 21.


Tissue Engineering in Orthopaedics.

Tatara AM, Mikos AG.

J Bone Joint Surg Am. 2016 Jul 6;98(13):1132-9. doi: 10.2106/JBJS.16.00299. Review.


Factors affecting patient outcome in primary cutaneous aspergillosis.

Tatara AM, Mikos AG, Kontoyiannis DP.

Medicine (Baltimore). 2016 Jun;95(26):e3747. doi: 10.1097/MD.0000000000003747. Review.


Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae.

Bellanger AP, Tatara AM, Shirazi F, Gebremariam T, Albert ND, Lewis RE, Ibrahim AS, Kontoyiannis DP.

J Infect Dis. 2016 Jul 1;214(1):114-21. doi: 10.1093/infdis/jiw090. Epub 2016 Mar 16.


Injectable dual-gelling cell-laden composite hydrogels for bone tissue engineering.

Vo TN, Shah SR, Lu S, Tatara AM, Lee EJ, Roh TT, Tabata Y, Mikos AG.

Biomaterials. 2016 Mar;83:1-11. doi: 10.1016/j.biomaterials.2015.12.026. Epub 2015 Dec 31.


2015 Lifetime Achievement Award of Tissue Engineering and Regenerative Medicine International Society-Americas: Antonios G. Mikos, PhD.

Tatara AM, Mikos AG.

Tissue Eng Part A. 2016 Jan;22(1-2):1-2. doi: 10.1089/ten.tea.2015.29000.agm. Epub 2015 Dec 18. No abstract available.


Biodegradable, phosphate-containing, dual-gelling macromers for cellular delivery in bone tissue engineering.

Watson BM, Vo TN, Tatara AM, Shah SR, Scott DW, Engel PS, Mikos AG.

Biomaterials. 2015 Oct;67:286-96. doi: 10.1016/j.biomaterials.2015.07.016. Epub 2015 Jul 21.


Infected animal models for tissue engineering.

Tatara AM, Shah SR, Livingston CE, Mikos AG.

Methods. 2015 Aug;84:17-24. doi: 10.1016/j.ymeth.2015.03.025. Epub 2015 Apr 2. Review.


Autologously generated tissue-engineered bone flaps for reconstruction of large mandibular defects in an ovine model.

Tatara AM, Kretlow JD, Spicer PP, Lu S, Lam J, Liu W, Cao Y, Liu G, Jackson JD, Yoo JJ, Atala A, van den Beucken JJ, Jansen JA, Kasper FK, Ho T, Demian N, Miller MJ, Wong ME, Mikos AG.

Tissue Eng Part A. 2015 May;21(9-10):1520-8. doi: 10.1089/ten.TEA.2014.0426. Epub 2015 Mar 3.


In vivo bioreactors for mandibular reconstruction.

Tatara AM, Wong ME, Mikos AG.

J Dent Res. 2014 Dec;93(12):1196-202. doi: 10.1177/0022034514547763. Epub 2014 Aug 19. Review.


The role of muscle loading on bone (Re)modeling at the developing enthesis.

Tatara AM, Lipner JH, Das R, Kim HM, Patel N, Ntouvali E, Silva MJ, Thomopoulos S.

PLoS One. 2014 May 21;9(5):e97375. doi: 10.1371/journal.pone.0097375. eCollection 2014.


Use of porous space maintainers in staged mandibular reconstruction.

Henslee AM, Spicer PP, Shah SR, Tatara AM, Kasper FK, Mikos AG, Wong ME.

Oral Maxillofac Surg Clin North Am. 2014 May;26(2):143-9. doi: 10.1016/j.coms.2014.01.002. Review.


Gelatin carriers for drug and cell delivery in tissue engineering.

Santoro M, Tatara AM, Mikos AG.

J Control Release. 2014 Sep 28;190:210-8. doi: 10.1016/j.jconrel.2014.04.014. Epub 2014 Apr 16. Review.

Supplemental Content

Loading ...
Support Center